Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott W Fosko

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Dermatologic Therapy|June 27, 2015
Lichenoid reaction as a potential immune response marker of intratreatment histological response during successful vismodegib treatment for a giant basal cell carcinomaScott W Fosko, Melinda B Chu, Adam R Mattox, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 5, 2012
Letter: Skin cancer treatment fee comparisons inaccurateHoward W Rogers, Brett M Coldiron, Scott M Dinehart, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 12, 2015
Perineural Invasion in Atypical Fibroxanthoma of the Scalp and ForeheadScott W Fosko, Grant K Ghahramani, Jordan B Slutksy, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 4, 2019
Head and Neck Melanoma Incidence Trends in the Pediatric, Adolescent, and Young Adult Population of the United States and Canada, 1995-2014Haley N Bray, Matthew C Simpson, Zisansha S Zahirsha, et al.
JAMA Dermatology|November 29, 2013
Assessing health-related quality of life for advanced basal cell carcinoma and basal cell carcinoma nevus syndrome: development of the first disease-specific patient-reported outcome questionnairesSusan D Mathias, Mary-Margaret Chren, Hilary H Colwell, et al.
International Journal of Oncology|August 9, 2002
Evaluation of patients with clinically suspected melanoma recurrence: current practice patterns of plastic surgeonsJulie A Margenthaler, David Y Johnson, Katherine S Virgo, et al.
Missouri Medicine|May 31, 2012
A collaborative skin cancer educational program for adolescentsJason Brant, Caroline Arthur, Sofia Chaudhry, et al.
Journal of Skin Cancer|October 14, 2014
Evaluation of the definitions of "high-risk" cutaneous squamous cell carcinoma using the american joint committee on cancer staging criteria and national comprehensive cancer network guidelinesMelinda B Chu, Jordan B Slutsky, Maulik M Dhandha, et al.
The Journal of Investigative Dermatology|November 13, 2013
Properly selected skin cancer treatments are very effectiveHoward W Rogers, Eric Armbrecht, Brett M Coldiron, et al.
Journal of the American Academy of Dermatology|December 15, 2019
Efficacy, rate of tumor response, and safety of a short course (12-24 weeks) of oral vismodegib in various histologic subtypes (infiltrative, nodular, and superficial) of high-risk or locally advanced basal cell carcinoma, in an open-label, prospective case series clinical trialScott W Fosko, Melinda B Chu, Eric Armbrecht, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Dermatologic Therapy|June 27, 2015
Lichenoid reaction as a potential immune response marker of intratreatment histological response during successful vismodegib treatment for a giant basal cell carcinomaScott W Fosko, Melinda B Chu, Adam R Mattox, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 5, 2012
Letter: Skin cancer treatment fee comparisons inaccurateHoward W Rogers, Brett M Coldiron, Scott M Dinehart, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 12, 2015
Perineural Invasion in Atypical Fibroxanthoma of the Scalp and ForeheadScott W Fosko, Grant K Ghahramani, Jordan B Slutksy, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 4, 2019
Head and Neck Melanoma Incidence Trends in the Pediatric, Adolescent, and Young Adult Population of the United States and Canada, 1995-2014Haley N Bray, Matthew C Simpson, Zisansha S Zahirsha, et al.
JAMA Dermatology|November 29, 2013
Assessing health-related quality of life for advanced basal cell carcinoma and basal cell carcinoma nevus syndrome: development of the first disease-specific patient-reported outcome questionnairesSusan D Mathias, Mary-Margaret Chren, Hilary H Colwell, et al.
International Journal of Oncology|August 9, 2002
Evaluation of patients with clinically suspected melanoma recurrence: current practice patterns of plastic surgeonsJulie A Margenthaler, David Y Johnson, Katherine S Virgo, et al.
Missouri Medicine|May 31, 2012
A collaborative skin cancer educational program for adolescentsJason Brant, Caroline Arthur, Sofia Chaudhry, et al.
Journal of Skin Cancer|October 14, 2014
Evaluation of the definitions of "high-risk" cutaneous squamous cell carcinoma using the american joint committee on cancer staging criteria and national comprehensive cancer network guidelinesMelinda B Chu, Jordan B Slutsky, Maulik M Dhandha, et al.
The Journal of Investigative Dermatology|November 13, 2013
Properly selected skin cancer treatments are very effectiveHoward W Rogers, Eric Armbrecht, Brett M Coldiron, et al.
Journal of the American Academy of Dermatology|December 15, 2019
Efficacy, rate of tumor response, and safety of a short course (12-24 weeks) of oral vismodegib in various histologic subtypes (infiltrative, nodular, and superficial) of high-risk or locally advanced basal cell carcinoma, in an open-label, prospective case series clinical trialScott W Fosko, Melinda B Chu, Eric Armbrecht, et al.
Pageof 4